MedPath

Comparison of anesthesia effectiveness and safety of 0.5% Levobupivacaine and 0.5% Ropivacaine in inferior alveolar nerve block among patients undergoing lower impacted wisdom tooth removal.

Phase 4
Conditions
Health Condition 1: K011- Impacted teeth
Registration Number
CTRI/2023/10/059014
Lead Sponsor
SHARAD PAWAR DENTAL COLLEGE
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

1.Individuals with ASA Gr I status

2.Individuals between 18 to 40 years

3.Presence of at least one asymptomatic impacted mandibular third molar having moderately difficult score Class II Position B.

Exclusion Criteria

1.Patient who has history of drug dependence.

2.Patients with systemic disease such as HTN, DM, blood dyscrasias, immunocompromised status.

3.Patients who is chronic smoker.

4.Patients with allergy to local anesthetic agents used in the study.

5.Patients who is Pregnant and nursing mother.

6.Females who are on oral contraceptives.

7.Patients undergoing treatment with antibiotics and anti-inflammatory drugs.

8.Patient showing signs of any local infection like pericoronitis/pterygomandibular space infection.

9.Patient who shows presence of any chronic facial pain on the side of administration.

10.Patient whose radiograph shows Inferior alveolar canal approximation.

11.Patients who have any psychiatric illness

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
1)Pain threshold2) Duration of postoperative analgesia <br/ ><br>3) Time to rescue analgesic 4)Adverse effects <br/ ><br>Timepoint: 1)WITHIN 24 HOURS 2)WITHIN 24 HOURS <br/ ><br>3) WITHIN 24 HOURS 4)WITHIN 24 HOURS
Secondary Outcome Measures
NameTimeMethod
1)Latency of anesthesia 2)Total analgesic requirements 3)Mean VAS scoreTimepoint: TOTAL 24 HOURS
© Copyright 2025. All Rights Reserved by MedPath